Your browser is no longer supported. Please, upgrade your browser.
GSK GlaxoSmithKline plc daily Stock Chart
GlaxoSmithKline plc
Index- P/E8.45 EPS (ttm)5.10 Insider Own0.20% Shs Outstand2.38B Perf Week3.04%
Market Cap102.64B Forward P/E16.38 EPS next Y2.63 Insider Trans0.00% Shs Float2.38B Perf Month0.42%
Income12.30B PEG14.08 EPS next Q0.60 Inst Own8.90% Short Float0.17% Perf Quarter11.53%
Sales34.94B P/S2.94 EPS this Y204.10% Inst Trans-2.71% Short Ratio1.23 Perf Half Y11.53%
Book/sh1.67 P/B25.80 EPS next Y13.22% ROA1.10% Target Price47.00 Perf Year3.37%
Cash/sh2.75 P/C15.66 EPS next 5Y0.60% ROE12.20% 52W Range35.12 - 43.23 Perf YTD11.64%
Dividend2.22 P/FCF- EPS past 5Y40.20% ROI41.40% 52W High-0.32% Beta0.80
Dividend %5.15% Quick Ratio0.80 Sales past 5Y-3.40% Gross Margin66.40% 52W Low22.68% ATR0.52
Employees101192 Current Ratio1.10 Sales Q/Q10.80% Oper. Margin- RSI (14)62.25 Volatility0.65% 1.04%
OptionableYes Debt/Eq6.05 EPS Q/Q-96.50% Profit Margin2.60% Rel Volume0.57 Prev Close43.12
ShortableYes LT Debt/Eq5.61 EarningsApr 27 Payout- Avg Volume3.25M Price43.09
Recom2.00 SMA201.99% SMA503.94% SMA2009.60% Volume1,848,687 Change-0.07%
Mar-30-16Upgrade Citigroup Neutral → Buy
Feb-26-16Initiated Cantor Fitzgerald Hold
Dec-09-15Upgrade BofA/Merrill Neutral → Buy
Dec-07-15Reiterated Argus Buy $52 → $48
Oct-20-15Upgrade Credit Suisse Underperform → Neutral
Sep-15-15Upgrade Exane BNP Paribas Underperform → Neutral
Sep-08-15Upgrade BofA/Merrill Underperform → Neutral
Jun-26-15Upgrade Liberum Sell → Hold
Jun-04-15Downgrade Morgan Stanley Overweight → Equal-Weight
May-20-15Resumed Citigroup Neutral
Apr-15-15Initiated Societe Generale Sell
Feb-19-15Reiterated Argus Buy $55 → $52
Aug-08-14Reiterated Argus Buy $65 → $55
Apr-23-14Upgrade Argus Hold → Buy
May-28-13Upgrade Deutsche Bank Hold → Buy
Jan-11-11Upgrade Jefferies Hold → Buy
Jun-02-10Upgrade Jefferies Hold → Buy
Feb-16-10Upgrade JP Morgan Underweight → Neutral $26
Jan-13-10Downgrade Credit Suisse Outperform → Underperform
Nov-24-09Initiated Leerink Swann Mkt Perform
May-26-16 05:00PM  Ionis Hits 3-Year Low As GlaxoSmithKline Drops Big Trial Plans
03:55PM  Why Alnylam Pharmaceuticals, Inc. Competed Higher Today at Motley Fool
01:54PM  Why Ionis Pharmaceuticals Plummeted Today at Motley Fool
12:32PM  [$$] Ionis's Shares Fall After Co-Developer Opts Against Starting Late-Stage Trial at The Wall Street Journal
11:16AM  Why Ionis Pharmaceuticals (IONS) Stock Is Tanking Today
10:47AM  Ionis Pharmaceuticals Inc (IONS) Plunges After GSK Foregos Phase 3 Study of TTRRx at Insider Monkey
May-25-16 11:21AM  Glaxo/Innoviva Report Positive COPD Data on Relvar Ellipta
09:35AM  Could the Worlds Most Effective Quit Smoking Aid be a Low Nicotine Cigarette US Public Health Officials Think So
08:04AM  4 Safe Stocks With Dividend Yields Above 5% at Motley Fool
May-24-16 10:40AM  Why this GSK news is good for workers in Zebulon at
09:36AM  3 Stocks With a Bigger Dividend Than Coca-Cola at Motley Fool
09:04AM  The Best Buys in Biopharma Today at Motley Fool
06:34AM  GSK lung drug succeeds in big UK study, after earlier miss Reuters
05:59AM  Salford Lung Study Results Show COPD Patients Treated With Relvar(R) Ellipta(R) Achieve Superior Reduction in Exacerbations Compared to 'Usual Care' Marketwired
May-23-16 05:53PM  EU lifts suicide warning on Pfizer's smoking-cessation pill
12:02PM  Behind the Worlds Top Drugmakers Approach to Zika Vaccine at Bloomberg
10:02AM  UK drugs watchdog warns it will struggle if Britain leaves EU Reuters
May-20-16 09:35PM  [$$] China Drug Deal Will Slash Prices of Three Top-Selling Treatments at The Wall Street Journal
11:57AM  Drugmakers eye volume growth as China cuts prices by up to 67 pct Reuters
10:41AM  [$$] China Drug Deal Will Slash Prices of Top Treatments at The Wall Street Journal
07:22AM  China slashes GSK, AstraZeneca drug prices in cost-cutting drive Reuters
May-19-16 08:14AM  Glaxo/Innoviva Unveil SUMMIT Study Data on Breo Ellipta
May-18-16 07:07PM  The Reasons behind Mercks Improving Profitability
12:21PM  GSK Presents Efficacy Data for Anoro(R) Ellipta(R) in COPD Patients Who Remained Symptomatic on Tiotropium Marketwired
12:20PM  GSK Present New Data From Breo(R) Ellipta(R) SUMMIT Study in Patients With COPD at ATS Conference Marketwired
May-16-16 11:50AM  3 things you should know about Greater Washingtons bioscience companies at
May-14-16 10:04PM  How Did GSKs HIV Business Perform in 1Q16?
May-11-16 01:05AM  Analyzing the Changes in Novartiss Valuation for 1Q16 Market Realist
May-10-16 02:54PM  Ionis Pharmaceuticals Inc Is Burning Partners' Cash (Thank Goodness There's Lots of It) at Motley Fool
May-09-16 04:07PM  Pfizers 1Q16 Earnings: Products That Saw Sales Drop Market Realist
03:43PM  Here's Why Amarin Corporation's Stock Rallied in April at Motley Fool
May-06-16 11:06AM  How Has GlaxoSmithKlines Valuation Changed in 1Q16? Market Realist
09:06AM  What Do Analysts Estimate for GlaxoSmithKline? Market Realist
May-05-16 12:53PM  Glaxo's CEO Search Will Be `Relatively Expensive,' Chairman Says at Bloomberg
12:21PM  GSK chairman rules out near-term break-up of drugmaker Reuters
11:06AM  How Did GlaxoSmithKlines Consumer Healthcare Perform in 1Q16? Market Realist
11:03AM  GlaxoSmithKline chairman says break-up not on the cards Reuters
10:20AM  Ionis Incurs Wider-than-Expected Loss in Q1, Stock Down Zacks
04:07AM  How Did GlaxoSmithKlines Global Pharmaceuticals Business Perform? Market Realist
May-04-16 10:40AM  GSK to sell, lease back, buildings in RTP at American City Business Journals
May-03-16 12:00PM  Why it took so long for Sarepta to start a big trial of its Duchenne drug at American City Business Journals
09:08AM  How Did GlaxoSmithKlines Pharmaceutical Segment Perform in 1Q16? Market Realist
08:40AM  Does This Upstart Pose a Threat to GlaxoSmithKline? at Motley Fool
07:08AM  How Is GlaxoSmithKlines Growth Trending? Market Realist
May-02-16 06:38PM  GSK CEO: Big pharma should keep investing in R&D at CNBC
05:13PM  ETFs with exposure to GlaxoSmithKline Plc : May 2, 2016 at Capital Cube
03:24PM  GSK CEO: Drug pricing in the US needs to change, here's h... CNBC
11:21AM  The Single Most Important Thing About GlaxoSmithKline's Q1 Report at Motley Fool
07:10AM  France gets G7 to discuss global regulation of medicine prices Reuters
Apr-30-16 10:47AM  GlaxoSmithKlines Stock Rose on Solid 1Q16 Earnings Market Realist
Apr-29-16 03:50PM  GSK reformulates mouthwash into a gel to prevent infections in newborns at American City Business Journals
09:21AM  GlaxoSmithKline Plc :GSK-US: Earnings Analysis: Q1, 2016 By the Numbers at Capital Cube
05:24AM  Glaxo's Mouthwash-Inspired Gel for Babies Wins EU Agency Backing at Bloomberg
Apr-28-16 03:12PM  How Did Eli Lilly Perform in 1Q16? Market Realist
01:06PM  GlaxoSmithKline (GSK) Q1 Earnings Lag, Revenues Up Y/Y Zacks
Apr-27-16 05:17PM  Advocates hold NYC protest over price of pneumonia vaccine AP
02:40PM  Glaxo Finally Finds Some Momentum at Bloomberg
11:55AM  GlaxoSmithKline Shares Boosted by Strong First-Quarter Update at TheStreet
10:48AM  [$$] GlaxoSmithKline Posts Healthy Profit With Earnings Rise at The Wall Street Journal
09:56AM  GSK finds axing doctor payments needn't torpedo sales Reuters
09:21AM  GSK sees rise in sales of vaccines, healthcare products AP
09:11AM  Glaxo CEO: Price Pressure Continues in United States Bloomberg
08:41AM  Glaxo (GSK) Misses on Q1 Earnings, Revenues Rise Y/Y Zacks
07:30AM  [$$] Zymeworks Forms Second Collaboration With GlaxoSmithKline at The Wall Street Journal
07:23AM  New products and vaccines a shot in the arm for GSK at CNBC
07:10AM  Better margins and new drugs keep GlaxoSmithKline on track Reuters
07:05AM  Glaxo Profit Rises for First Time Since 2013, Tops Estimates at Bloomberg
Apr-26-16 07:05PM  Other Drugs under Development at Ionis Pharmaceuticals Market Realist
06:46PM  [$$] Welcome initiatives in affordable therapies at Financial Times
07:27AM  [$$] Allied Minds Supports Bristol-Myers Partnership With $80M Fund at The Wall Street Journal
Apr-25-16 11:34AM  Novartiss 1Q16 Earnings Got a Neutral Response from Investors Market Realist
11:34AM  Novartis Reported Operational Growth in Its 1Q16 Earnings Market Realist
07:08AM  Big Drug Stocks to Report This Week: LLY, GSK, VRTX, BMY, ABBV Zacks
Apr-24-16 07:16PM  [$$] Vaccine development needs global alliance at Financial Times
07:13PM  [$$] Vaccines are among big pharma's best-selling products at Financial Times
Apr-22-16 06:50PM  Study: No suicide risk for anti-smoking pills Chantix, Zyban AP
12:08PM  Glaxo (GSK) Q1 Earnings: What's in Store for the Stock? Zacks
12:30AM  [$$] Glaxo Investors Want CEO Who Can Revitalize R&D at The Wall Street Journal
Apr-21-16 09:00AM  How These Drug Manufacturers BMY, LLY, AZN, and GSK are Performing Accesswire
05:30AM  [$$] Glaxo Investors Want CEO Who Can Revitalize R&D at The Wall Street Journal
Apr-20-16 09:53AM  Searching for Volatility and Value in a Low Vol Market Bloomberg
09:05AM  GlaxoSmithKline & California research institute create center to study brain disorders at American City Business Journals
12:00AM  Glaxo May Need to Boost Pay to Lure U.S. CEO Candidates at Bloomberg
Apr-19-16 03:41PM  Jim Cramer -- Johnson & Johnson Is a Standout Among Drug Stocks at TheStreet
12:03PM  Jim Cramer -- Skip GlaxoSmithKline, but Buy Johnson & Johnson at TheStreet
Apr-16-16 02:18PM  The Race to Cure the Zika Virus is On, and This Company May Have the Best Solution at Motley Fool
Apr-15-16 09:07AM  Understanding Ionis Pharmaceuticals 2015 Revenue Stream
Apr-13-16 02:40PM  Glaxo, IP and PetMed Poised to Go Higher at TheStreet
Apr-12-16 08:10AM  3 Nominations for Big Pharma's Riskiest Pipeline -- and Why They Qualify at Motley Fool
01:05AM  How Is Novo Nordisk Doing in the Diabetes Space?
Apr-11-16 10:07AM  Consumer Healthcare Should Be a Key Driver of Perrigos 2016 Growth
Apr-09-16 03:24PM  Here's Why Dynavax Technologies Corporation's Stock Gained 14.5% In March at Motley Fool
06:42AM  The Biggest Threat to Novavax Stock at Motley Fool
Apr-08-16 05:26PM  Market Dynamics Should Strengthen Perrigos OTC Business in 2016
04:40PM  Ionis Tanks, FDA Clinical Hold on IONIS-TTRRx Phase III Study
10:05AM  How Risky Is Dynavax Technologies Stock? at Motley Fool
08:15AM  3 Healthcare Funds to Buy on Biotech Rebound
Apr-07-16 01:19PM  Why Ionis Pharmaceuticals Inc Couldn't Hold Its Price Today at Motley Fool
12:10PM  Ionis Stumbles on FDA Clinical Hold
11:39AM  Here's Why Ionis Pharma (IONS) Stock is Sinking Today at TheStreet
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company offers pharmaceutical products in the therapeutic areas, including respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health areas. The company's wellness products include Panadol and Panadol Cold & Flu for headache, joint pain, fever, and cold symptoms; ENO and Tums that are immediate relief antacids; and Nicorette (US), Nicoderm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to smoking reduction and cessation. Its oral health products comprise Sensodyne to treat and prevent dental sensitivity and acid erosion; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; and Aquafresh for the prevention of caries, gum disease, and bad breath. The company's nutrition products include Horlicks, a nutritional beverages and food; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, as well as Zovirax and Abreva to treat and prevent the onset of cold sores. GlaxoSmithKline plc has collaboration agreements with Universit de Sherbrooke and Pfizer Inc.; development agreement, and R and D collaboration with Propeller Health; R and D collaboration agreement with Valneva SE; and collaboration and license agreement with Idera pharmaceuticals, Inc. The company was founded in 1935 and is headquartered in Brentford, the United Kingdom.